reviewInternational Journal of Molecular SciencesMay 28, 2025GOLD OA

Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies

Medical University of Lublin

PubMed
Indexed incrossrefpubmed

Abstract

Thyroid cancer (TC) invariably remains the most prevalent endocrine cancer in the world. Major histological forms of TC include papillary (PTC), follicular (FTC), medullary (MTC), and anaplastic thyroid carcinoma (ATC), each of which has a unique clinical and molecular profile. The incidence rate of TC is higher in females, and unfortunately, it has tended to increase over the last several years. Yet the treatment of advanced or aggressive TC forms has improved recently because of developments in immunotherapy and targeted medicines, including PD-1 inhibitors and tyrosine kinase inhibitors (e.g., lenvatinib, sorafenib). Imaging, fine-needle aspiration biopsies, and molecular testing are implemented in the…

Citation impact

71
total citations
FWCI
65.23
Percentile
100%
References
334
Citations per year

Authors

7

Topics & keywords

Keywords
  • Medicine
  • Sorafenib
  • Thyroid cancer
  • Oncology
  • Lenvatinib
  • Internal medicine
  • Targeted therapy
  • Thyroid carcinoma
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.